Nicholas Galakatos, Director at Ophthotech Corp. (OPHT), sold 1,500 shares at $60.00 ($90K) on 2015-11-18, disclosed to the SEC on 2015-11-19.
Scheduled sale ($90k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 500 | $30K | 33.3% |
| 2 | $60.00 | 1,000 | $60K | 66.7% |
| Total | $60.00 avg | 1,500 | $90K | 100% |
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |